Pathology of myocardial infarction, coronary artery disease, plaque disruption, and the vulnerable atherosclerotic plaque

Diagnostic Histopathology

Volumn 18, Issue 11, 2012, Pages 478-483

  Stone, James R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Atherosclerosis; Macrophages; Myeloperoxidase; Neutrophils; Plaque rupture plaque erosion; Thin cap fibroatheroma; Vulnerable plaque

Indexed keywords

C REACTIVE PROTEIN; COCAINE; COMPLEMENT COMPONENT C4D; EOSIN; HEMATOXYLIN; MYELOPEROXIDASE; PROTEOGLYCAN;

ARTERY INTIMA PROLIFERATION; ARTERY THROMBOSIS; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR MORTALITY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; CORONARY ARTERY THROMBOSIS; FIBROATHEROMA; HEART DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HODGKIN DISEASE; HUMAN; HYPEREOSINOPHILIA; IMMUNOHISTOCHEMISTRY; INTRAVASCULAR ULTRASOUND; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEAR INFRARED SPECTROSCOPY; NEUTROPHIL; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; RADIOFREQUENCY; REVIEW; RHEUMATOID ARTHRITIS; SCAR FORMATION; SMOKING CESSATION; SMOOTH MUSCLE FIBER; STENOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VASOSPASM;

EID: 84869888786     PISSN: 17562317     EISSN: 18767621     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2012.09.001     Document Type: Review

References (25)

1. Thiene G., Basso C. Myocardial infarction: a paradigm of success in modern medicine. Cardiovasc Pathol 2010, 19:1-5.
2. Fishbein M.C., Maclean D., Maroko P.R. Histopathologic evolution of myocardial infarction. Chest 1978, 73:843-849.
3. Qiao Q., Tervahauta M., Nissinen A., Tuomilehto J. Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men. Eur Heart J 2000, 21:1621-1626.
4. Cook D.G., Pocock S.J., Shaper A.G., Kussick S.J. Giving up smoking and the risk of heart attacks: a report from the British Regional Heart Study. Lancet 1986, 328:1376-1380.
5. Cizek S.M., Bedri S., Talusan P., Silva N., Lee H., Stone J.R. Risk factors for atherosclerosis and the development of preatherosclerotic intimal hyperplasia. Cardiovasc Pathol 2007, 16:344-350.
6. Senzaki H. Long-term outcome of Kawasaki disease. Circulation 2008, 118:2763-2772.
7. Veinot J.P., Edwards W.D. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol 1996, 27:766-773.
8. Stary H.C., Blankenhorn D.H., Chandler A.B., et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1992, 85:391-405.
9. Schwartz S.M., deBlois D., O'Brien E.R. The intima. Soil for atherosclerosis and restenosis. Circ Res 1995, 77:445-465.
10. Stary H.C., Chandler A.B., Glagov S., et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994, 89:2462-2478.
11. Chapman I. Morphogenesis of occluding coronary artery thrombosis. Archiv Pathol 1965, 80:256-261.
12. Constantinides P. Plaque fissures in human coronary thrombosis. J Atheroscler Res 1966, 6:1-17.
13. Friedman M., Van den Bovenkamp G.J. The pathogenesis of a coronary thrombus. Am J Pathol 1966, 48:19-44.
14. Fishbein M.C. The vulnerable and unstable atherosclerotic plaque. Cardiovasc Pathol 2010, 19:6-11.
15. Virmani R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006, 47:C13-C18.
16. Naruko T., Ueda M., Haze K., et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002, 106:2894-2900.
17. Tavora F., Ripple M., Li L., Burke A.P. Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques. BMC Cardiovasc Disord 2009, 9:27.
18. Sugiyama S., Okada Y., Sukhova G.K., Virmani R., Helnecke J.W., Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 2001, 158:879-891.
19. Ionita M.G., van den Borne P., Catanzariti L.M., et al. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol 2010, 30:1842-1848.
20. Zhang R., Brennan M.L., Fu X., et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001, 286:2136-2142.
21. Baldus S., Heeschen C., Meinertz T., et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003, 108:1440-1445.
22. Ferrante G., Nakano M., Prati F., et al. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation 2010, 122:2505-2513.
23. Peacock W.F., Nagurney J., Birkhahn R., et al. Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum. Am Heart J 2011, 162:893-899.
24. Stone G.W., Maehara A., Lansky A.J., et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011, 364:226-235.
25. Calvert P.A., Obaid D.R., O'Sullivan M., et al. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) study. J Am Coll Cardiol Img 2011, 4:894-901.